Deciphering the anti-cancer mechanism of ferulic acid in gastrointestinal cancers using network pharmacology, simulations, and in vitro validation
Authors:
- Varadhan PrathibaVPVaradhan Prathiba
- Megala JayaramanMJMegala Jayaraman
Open Access
- 1 January 2026
- journal article
- Published by ScopeMed in Journal of Advanced Biotechnology and Experimental Therapeutics
- Vol. 9 (1) , 135-157
Abstract
Ferulic acid (FA) was reported for its chemoprotective anticancer properties in various cancers, including lung and breast cancers. However, the exact molecular mechanism of FA targeting the JAK-STAT pathway in gastrointestinal (GI) cancers such as colon and gastric cancers, has yet to be explored. Hence, our study aims to decipher the molecular mechanism of FA by targeting the JAK-STAT pathway in GI cancers through an integrated approach of network pharmacology and molecular simulation, which would provide a new targeted therapy for GI cancers. Subsequently, various in vitro experimental validation assays, including cell proliferation assay, AO/EtBr, DAPI staining, gene and protein expression analysis, were performed on SW620 and AGS cell lines to check for the anticancer potential of FA. A total of 92 potential FA targets for GI cancer treatment were identified. Moreover, 370 entries and 72 pathways were discovered through GO and KEGG analysis. Network pharmacology data indicated that FA targets STAT3 via the JAK-STAT pathway. The molecular docking and simulations showed a high binding affinity between FA and STAT3 (-6.7 kcal/mol). Also, FA exhibited strong cytotoxic effects on GI cancer cell lines (SW620- IC50 302 µg/ ml and AGS-IC50 205 µg/ml), apoptosis validated by apoptotic staining. Further, the gene and protein expression analysis revealed the downregulation of JAK2 and STAT3 of the JAK/STAT pathway. Thus, our approach with network pharmacology and in vitro experiments has suggested that FA could be a promising drug against GI cancers.Keywords
This publication has 30 references indexed in Scilit:
- Network pharmacology, molecular docking, and molecular dynamics simulation analysis reveal the molecular mechanism of halociline against gastric cancerMolecular Diversity, 2024
- Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancerNaunyn-Schmiedeberg's Archives of Pharmacology, 2024
- Molecular mechanism of ferulic acid and its derivatives in tumor progressionPharmacological Reports, 2023
- Exploring the mechanism of Cremastra Appendiculata (SUANPANQI) against breast cancer by network pharmacology and molecular dockingComputational Biology and Chemistry, 2021
- Targeting key transcriptional factor STAT3 in colorectal cancerMolecular and Cellular Biochemistry, 2021
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In VivoCancer Cell, 2019
- Heme Oxygenase 2 Binds Myristate to Regulate Retrovirus Assembly and TLR4 SignalingCell Host & Microbe, 2017
- Potential applications of ferulic acid from natural sourcesBiotechnology Reports, 2014
- Biochemical and Structural Studies of ASPP Proteins Reveal Differential Binding to p53, p63, and p73Structure, 2008